Cargando…
A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies
BACKGROUND: The higher recurrence rate of hepatocellular carcinoma (HCC) needs to be urgently controlled. However, definitive markers are lacking for patients with recurrence of HCC after undergoing minimal invasive therapies—local ablation combined with transcatheter arterial chemoembolization (TAC...
Autores principales: | Wang, Qi, Ma, Liang, Li, Jianjun, Yuan, Chunwang, Sun, Jianping, Li, Kang, Qin, Ling, Zang, Chaoran, Zhao, Yanan, Zhao, Yan, Zhang, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930388/ https://www.ncbi.nlm.nih.gov/pubmed/31908536 http://dx.doi.org/10.2147/CMAR.S224711 |
Ejemplares similares
-
Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma
por: Guo, Dandan, et al.
Publicado: (2023) -
The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study
por: Wang, Qi, et al.
Publicado: (2021) -
Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation
por: Zang, Chaoran, et al.
Publicado: (2022) -
Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy
por: Liu, Biyu, et al.
Publicado: (2023) -
The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy
por: Wang, Qi, et al.
Publicado: (2022)